pffff omg. Do you hear yourself... Here: The pitch... its breaking out. Insider buys. $10 cash/share on the books. A stock trading at $10
I run scanners Stoney. Based on TA and fundamentals. When a stock spits out... I know its good because I built the scanner based on YEARS of accumulated knowledge. Wtf do you use? Analyst upgrades on the front page of Seeking Alpha every morning with a cyt and paste of the article.
Here... I'll go Stoney: Quanterix Corporation (QTRX) Loses 53.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks Equity Research August 11, 2022, 8:35 AM·2 min read In this article: QTRX Quanterix Corporation (QTRX) has been on a downward spiral lately with significant selling pressure. After declining 53.2% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.
IRA Alert***** I'm going to add NIKE here- NIKE, Inc. (NKE)- Back to school heading up! NYSE - Nasdaq Real Time Price. 114.28+1.14 (+1.01%) As of 02:45PM EDT.
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
GBA UPGRADE TO BUY NKE LOL! You got to be careful-- you had some letters flipped around if the other had existed the HF would of bought it for you!
Oh yikes Sorry. I see... This is a 6 Flags story-- your favorite stock just really crashed! This is a double down situation? Quanterix stock crashes ~60% on weak Q2 results, FY guidance and new strategic plan Aug. 09, 2022 11:02 AM ETQuanterix Corporation (QTRX) Quanterix (NASDAQ:QTRX) stock plunged 60.3% to $6.54 in Tuesday morning trading after a triple whammy of weak Q2 results, disappointing guidance and a strategic realignment plan involving layoffs. Billerica, Mass.-based QTRX offers biomarker detection technology and biomarker testing services. It also makes the Simoa branded assay kits, which provide various reagents to perform analytical tests.